Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Mach7 Technologies ( (AU:M7T) ).
Mach7 Technologies Limited has announced an update on its ongoing share buy-back program, with a total of 4,680,000 ordinary fully paid securities repurchased, including 40,000 on the previous day. This buy-back initiative is part of the company’s strategy to optimize capital structure and enhance shareholder value.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology sector, focusing on providing innovative healthcare solutions. The company specializes in developing software for medical imaging and data management, catering primarily to the healthcare industry.
Average Trading Volume: 249,870
Technical Sentiment Signal: Sell
Current Market Cap: A$91.67M
For detailed information about M7T stock, go to TipRanks’ Stock Analysis page.